Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.02 by 200 percent. This is a 90 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $115.927 million which beat the analyst consensus estimate of $110.374 million by 5.03 percent. This is a 18.34 percent increase over sales of $97.964 million the same period last year.